XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
RESTRUCTURING (Tables)
9 Months Ended
Dec. 28, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve by Type of Cost
The following table summarizes the activity for restructuring reserves related to the portfolio rationalization initiatives and the 2020 Program for the nine months ended December 28, 2024, which relates to employee severance, other employee costs, inventory reserves and lease termination fees:
(In thousands)Portfolio Rationalization2020 ProgramTotal
Balance at March 30, 2024
$11,309 $485 $11,794 
Costs incurred, net of reversals12,296 633 12,929 
Payments(10,837)(652)(11,489)
Non-cash adjustments(8,616)— (8,616)
Balance at December 28, 2024
$4,152 $466 $4,618 
Schedule of Restructuring and Related Costs
The following presents the restructuring costs by line item within our accompanying unaudited Condensed Consolidated Statements of Income and Comprehensive Income:
 Three Months EndedNine Months Ended
(In thousands) December 28,
2024
December 30,
2023
December 28,
2024
December 30,
2023
Cost of goods sold$3,027 $7,065 $11,158 $7,329 
Research and development(4)343 (16)343 
Selling, general and administrative expenses492 560 1,787 371 
Total$3,515 $7,968 $12,929 $8,043 
The tables below present restructuring and restructuring related costs by reportable segment:
Restructuring costsThree Months EndedNine Months Ended
(In thousands) December 28, 2024December 30, 2023December 28, 2024December 30, 2023
Plasma$77 $33 $284 $(164)
Blood Center685 4,546 4,241 4,546 
Hospital774 2,503 1,404 2,745 
Corporate1,979 886 7,000 916 
Total$3,515 $7,968 $12,929 $8,043 
Restructuring related costsThree Months EndedNine Months Ended
(In thousands) December 28, 2024December 30, 2023December 28, 2024December 30, 2023
Plasma$37 $72 $263 $315 
Blood Center31 93 120 166 
Hospital(68)251 40 398 
Corporate1,468 1,987 5,134 5,675 
Total$1,468 $2,403 $5,557 $6,554 
Total restructuring and restructuring related costs$4,983 $10,371 $18,486 $14,597